Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.

Antimicrobial Agents and Chemotherapy
Cyrus BacchiA B Clarkson

Abstract

DL-alpha-Difluoromethylornithine is an enzyme-activated inhibitor of ornithine decarboxylase and an antagonist of polyamine metabolism that has been successful in clinical trials against West African sleeping sickness caused by Trypanosoma brucei gambiense. Its potential for use against the more virulent East African form of the disease, caused by T. brucei rhodesiense, is not certain. We examined 14 East African clinical isolates from the Kenya Trypanosomiasis Research Institute strain bank plus 2 established isolates for susceptibility to DL-alpha-difluoromethylornithine and to standard trypanocides. Seven of 16 strains were partially or totally refractory to DL-alpha-difluoromethylornithine in our test system. Four strains were also refractory to arsenical drugs, and five were refractory to diamidines. The results indicate that other novel agents or combinations of established agents may be needed for chemotherapy of East African disease.

References

May 1, 1976·The Journal of protozoology·D Damper, C L Patton
Jan 1, 1976·Transactions of the Royal Society of Tropical Medicine and Hygiene·J Williamson
Aug 1, 1979·International Journal for Parasitology·F W JenningsG M Urquhart
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A H FairlambA Cerami
Jan 2, 1987·Molecular and Biochemical Parasitology·M A Phillips, C C Wang
Oct 1, 1987·Molecular and Biochemical Parasitology·V BellofattoG A Cross
Jan 1, 1971·Transactions of the Royal Society of Tropical Medicine and Hygiene·B S Gill
Jan 1, 1983·Transactions of the Royal Society of Tropical Medicine and Hygiene·J Williamson
Jan 1, 1984·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Dukes
Jan 1, 1983·Transactions of the Royal Society of Tropical Medicine and Hygiene·W C Gibson, J K Gashumba
Jun 18, 1982·Science·A B Clarkson, B O Amole

❮ Previous
Next ❯

Citations

Feb 1, 1995·Molecular and Biochemical Parasitology·B J BergerA H Fairlamb
May 1, 1993·Parasitology Today·C J Bacchi
Aug 1, 1994·International Journal of Antimicrobial Agents·M Wéry
Jul 15, 2003·Experimental Parasitology·George W LubegaRoger K Prichard
Dec 16, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·J ClerinxT Vervoort
May 14, 1999·Parasitology Today·M P Barrett, A H Fairlamb
Jun 12, 2003·Parasitology International·Yoshisada YabuNobuo Ohta
Jun 19, 2009·Journal of Medicinal Chemistry·Robert A Casero, Patrick M Woster
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F M VellieuxH C Watson
Jul 1, 1991·Antimicrobial Agents and Chemotherapy·C J BacchiN Yarlett
Aug 27, 2009·Interdisciplinary Perspectives on Infectious Diseases·Cyrus J Bacchi
Jul 17, 2013·Parasites & Vectors·Nick Van ReetPhilippe Büscher
Dec 3, 2010·PLoS Pathogens·Isabel M VincentMichael P Barrett
Apr 1, 1994·European Journal of Biochemistry·M L CunninghamA H Fairlamb
Aug 11, 2012·International Journal for Parasitology·J NiemandK Kirk
Sep 9, 2009·Bioorganic & Medicinal Chemistry Letters·Tien L HuangNigel Yarlett
Oct 9, 2007·International Journal of Antimicrobial Agents·Tien L HuangIsaac O Donkor
Jan 26, 2010·Essays in Biochemistry·M D Thulani SenanayakePatrick M Woster
Apr 23, 2016·Pharmaceuticals·Jean J Vanden EyndeTien L Huang
Aug 27, 2016·Scientific Reports·Sarah M ThomasKojo Mensa-Wilmot
Sep 13, 2002·Tropical Medicine & International Health : TM & IH·Bokelo Mpia, Jacques Pépin
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·C J BacchiW Zhou
Jan 23, 2020·Tropical Medicine and Infectious Disease·Harry P De Koning
Feb 10, 2020·Trends in Parasitology·Robert E Molestina, Timothy T Stedman
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·R Kaminsky, R Brun
Mar 17, 2006·Journal of Medicinal Chemistry·Magdalena RappStanislaw F Wnuk
Apr 3, 2001·Experimental Parasitology·K NishimuraS Kozaki
Jul 1, 1995·Clinical Microbiology Reviews·M Khaw, C B Panosian
Feb 14, 1997·Journal of Medicinal Chemistry·K L SeleyC J Bacchi
Oct 23, 1997·Antimicrobial Agents and Chemotherapy·C J BacchiJ R Sufrin
Jun 1, 1996·Antimicrobial Agents and Chemotherapy·R BrunH Mett
Jun 1, 1996·Antimicrobial Agents and Chemotherapy·C J BacchiY Bühler
Mar 7, 2003·Journal of Medicinal Chemistry·Isaac O DonkorCyrus Bacchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.